Depomed wins Nucynta patent dispute; may spur sale talks

(Reuters) – A court ruled in Depomed Inc’s favor in a patent dispute over its opioid drug, Nucynta, a decision that could help pave the way for the drug maker to explore a sale.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *